Hyperfine (HYPR) Income towards Parent Company (2021 - 2026)
Hyperfine's (HYPR) quarterly Income towards Parent Company came in at -$8.6 million in Q1 2026, up 8.44% YoY from -$8.0 million in Q1 2025, and down 45.86% on a QoQ basis from -$5.9 million in Q4 2025.
Hyperfine (HYPR) Income towards Parent Company (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Income towards Parent Company data on file, last reported at -$8.6 million in Q1 2026.
- Quarterly Income towards Parent Company rose 8.44% year-over-year to -$8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$34.8 million (up 13.68% YoY) and the FY2025 annual result came in at -$35.6 million, up 12.64% from the prior year.
- Income towards Parent Company declined to -$8.6 million in Q1 2026, from -$5.9 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$5.9 million in Q4 2025 to a low of -$23.8 million in Q1 2022.
- A 5-year average of -$11.9 million and a median of -$10.6 million in 2023 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2022 — Income towards Parent Company sank 205.04% — and 2023, when it surged 54.07%.
- Tracing HYPR's Income towards Parent Company over 5 years: stood at -$13.1 million in 2022, then gained by 18.19% to -$10.7 million in 2023, then rose by 2.75% to -$10.4 million in 2024, then surged by 43.1% to -$5.9 million in 2025, then slumped by 45.86% to -$8.6 million in 2026.
- The last three Income towards Parent Company figures came in at -$8.6 million (Q1 2026), -$5.9 million (Q4 2025), and -$11.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Hyperfine | 89.22 Mn | 44.45 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.30 Mn |
| Mar 31, 2026 | -8.62 Mn |
| Dec 31, 2025 | -5.91 Mn |
| Sep 30, 2025 | -11.02 Mn |
| Jun 30, 2025 | -9.23 Mn |
| Mar 31, 2025 | -9.42 Mn |
| Dec 31, 2024 | -10.39 Mn |
| Sep 30, 2024 | -10.33 Mn |
| Jun 30, 2024 | -10.16 Mn |
| Mar 31, 2024 | -9.85 Mn |
| Dec 31, 2023 | -10.68 Mn |
| Sep 30, 2023 | -10.76 Mn |
| Jun 30, 2023 | -10.64 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -13.06 Mn |
| Sep 30, 2022 | -13.17 Mn |
| Jun 30, 2022 | -23.16 Mn |
| Mar 31, 2022 | -23.78 Mn |
| Dec 31, 2021 | -26.09 Mn |
| Sep 30, 2021 | -16.39 Mn |